Fact Source: Financial Supervisory Service DART
💡 3-Second Summary
HPSP will issue and list 283,592 new common shares following the exercise of stock options.
📊 [Key Disclosure Contents & Summary Metrics]
1. Additional Listing Overview
- Disclosure Type: Additional Listing (Exercise of Stock Options)
- Company Name: HPSP Co., Ltd.
- Listing Date: January 17, 2025
- Type and Number of Additional Shares: 283,592 Common Shares
- Par Value per Share: KRW 500
- Total Issued Shares Post-Listing: 83,498,568 Common Shares
- Dividend Accrual Date for New Shares: January 1, 2025
2. Details of Stock Option Exercise
- 56,192 Common Shares: Exercise Price KRW 769 (18th Tranche, Exercise Date: January 3, 2025)
- 194,400 Common Shares: Exercise Price KRW 769 (18th Tranche, Exercise Date: January 3, 2025)
- 33,000 Common Shares: Exercise Price KRW 4,526 (19th Tranche, Exercise Date: January 3, 2025)
📝 Editor’s Comment (Key Follow-up Checkpoint)
📌 Increase in Outstanding Shares and Stock Dilution Effect
This disclosure indicates an increase in total outstanding shares as 283,592 new common shares are newly listed following stock option exercises. Reviewing the ratio of newly listed shares relative to total outstanding shares and their listing timeline is important for assessing potential equity dilution and liquidity changes in the market. Relevant updates can be verified under the “Total Number of Shares” and “Status of Grant and Exercise of Stock Options” sections in subsequent Regular Business Reports.
📢 Disclaimer and Source Information
Source: This content was structured and generated based on official submission data from the Financial Supervisory Service’s Data Analysis, Retrieval and Transfer System (DART).
Investment Risk Notice: This content is provided solely for informational and linguistic reference purposes. Under no circumstances does it constitute financial advice or a recommendation to buy or sell specific stocks. All investment decisions and financial liabilities rest entirely with the individual investor.
Contact: For compliance inquiries or copyright concerns, please contact ksb220805@gmail.com.
